VivoSim Labs (VIVS) Net Cash Flow (2010 - 2026)
VivoSim Labs (VIVS) posted quarterly Net Cash Flow of $747000.0 for Q1 2026, down 92.64% year-over-year from $10.2 million in Q1 2025, and up 130.89% quarter-over-quarter from -$2.4 million in Q4 2025.
VivoSim Labs (VIVS) Net Cash Flow (2010 - 2026) Analysis & Trends
VivoSim Labs' Net Cash Flow history runs 17 years deep, the most recent figure standing at $747000.0 for Q1 2026.
- In Q1 2026, Net Cash Flow fell 92.64% year-over-year to $747000.0; the TTM figure through Mar 2026 stood at -$6.3 million (down 174.76% YoY), while the FY2026 annual figure was -$6.3 million, down 174.76% from the prior year.
- Net Cash Flow for Q1 2026 stood at $747000.0, up from -$2.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $10.2 million in Q1 2025, with the low at -$13.1 million in Q2 2022.
- The 5-year median for Net Cash Flow is -$2.3 million (2023), against an average of -$1.5 million.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow plunged 866.59% in 2022, then soared 524.02% in 2025.
- VivoSim Labs' Net Cash Flow stood at $6.9 million in 2022, then plunged by 133.5% to -$2.3 million in 2023, then rose by 13.31% to -$2.0 million in 2024, then declined by 20.12% to -$2.4 million in 2025, then soared by 130.89% to $747000.0 in 2026.
- Business Quant data shows VIVS's Net Cash Flow at $747000.0 in Q1 2026, -$2.4 million in Q4 2025, and -$2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.35 Mn |
| Jun 30, 2026 | -3.35 Mn |
| Mar 31, 2026 | 747,000.00 |
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | -2.42 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 10.15 Mn |
| Mar 31, 2025 | 10.15 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | -3.01 Mn |
| Sep 30, 2024 | -3.01 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | -2.39 Mn |
| Mar 31, 2024 | -2.39 Mn |